HDAC9 and chronic obstructive pulmonary disease: We found that NTHi, a bacterial pathogen often isolated from the airways of patients with moderate to severe COPD [17, 19], induces partial steroid resistance ex vivo and reduces HDAC activity in vitro, thus offering a potential explanation for the observed reduction of HDAC in patients with advanced COPD.